Abattis Bioceuticals benefits from Emerald Health’s wealth of scientific knowledge, pharmaceutical connections, and access to capital, as well as a $2.5 million capital infusion into the subsidiary. The strong relationship between Abattis and a rapidly growing and respected licensed producer in Canada also paves the way for future joint ventures for its extraction technology and adds credibility to its ability to create laboratories – which is essential to its business model moving forward. http://420meta.com/emerald-health-expands-capabilities-with-northern-vine-labs/